New strategies for the prevention of stroke

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages 265-271

  Liu, Ai Jun ^a   Guo, Jin Min ^a   Xia, Weiliang ^b   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Arterial baroreflex; Folic acid; Hypertension; Pro inflammatory factor; Risk factor; Stroke prevention

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; CYANOCOBALAMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN; FOLIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEUKOCYTE ELASTASE; LIPOPROTEIN A; TELMISARTAN;

BRAIN INJURY; CALORIC RESTRICTION; CEREBROVASCULAR ACCIDENT; CORONARY RISK; DIABETES MELLITUS; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; POSTMENOPAUSE; PRESSORECEPTOR REFLEX; REVIEW; STROKE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLIC BEVERAGES; ANTI-INFLAMMATORY AGENTS; BAROREFLEX; CYTOKINES; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGESTINS; RISK FACTORS; SMOKING; STROKE; VITAMIN D DEFICIENCY;

EID: 75649151144     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05230.x     Document Type: Review

References (68)

1. Flynn RW, MacWalter RS, Doney AS. The cost of cerebral ischaemia. Neuropharmacology 2008 55 : 250 256.
2. World Health Organization. World Health Statistics 2008. World Health Organization, Geneva. 2008.
3. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics: 2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 117 : E25 146.
4. Rosamond W, Flegal K, Friday G. Heart Disease and Stroke Statistics: 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 115 : E69 171.
5. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. World Health Organization, Geneva. 2004.
6. Rosengren A, Hawken S, Ounpuu S et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004 364 : 953 962.
7. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004 364 : 937 952.
8. Hesse C, Charkoudian N, Liu Z, Joyner MJ, Eisenach JH. Baroreflex sensitivity inversely correlates with ambulatory blood pressure in healthy normotensive humans. Hypertension 2007 50 : 41 6.
9. La Rovere MT, Pinna GD, Hohnloser SH et al. Autonomic tone and reflexes after myocardial infarction. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 2001 103 : 2072 2077.
10. La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998 351 : 478 484.
11. Mortara A, La Rovere MT, Pinna GD et al. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997 96 : 3450 3458.
12. Milan A, Caserta MA, Del Colle S et al. Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. J. Hypertens. 2007 25 : 1655 1664.
13. Nasr N, Pavy-Le Traon A, Larrue V. Baroreflex sensitivity is impaired in bilateral carotid atherosclerosis. Stroke 2005 36 : 1891 1895.
14. Johansson M, Gao SA, Friberg P et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J. Hypertens. 2007 25 : 163 168.
15. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 2003 34 : 705 712.
16. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis 2005 183 : 41 7.
17. Shu H, Yi-Ming W, Xu LP, Miao CY, Su DF. Increased susceptibility of ventricular arrhythmia to aconitine in anesthetized rats is attributed to the inhibition of baroreflex. ClExp. Pharmacol. Physiol. 2004 31 : 249 253.
18. Shen FM, Guan YF, Xie HH, Su DF. Arterial baroreflex function determines the survival time in lipopolysaccharide-induced shock in rats. Shock 2004 21 : 556 560.
19. Liu AJ, Ling G, Wu J et al. Arterial baroreflex function is an important determinant on the acute cerebral ischemia in rats with middle cerebral artery occlusion. Life Sci. 2008 83 : 388 393.
20. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex: A novel target for preventing stroke in rat hypertension. Stroke 2007 38 : 1916 1923.
21. 2A receptors. ClExp. Pharmacol. Physiol. 2007 34 : 702 707.
22. Ma XJ, Shen FM, Liu AJ, Shi KY, Wu YL, Su DF. Clonidine, moxonidine, folic acid, and mecobalamin improve baroreflex function in stroke-prone, spontaneously hypertensive rats. Acta Pharmacol. S2007 28 : 1550 1558.
23. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation 2007 115 : 2119 2127.
24. Di Napoli M, Schwaninger M, Cappelli R et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: A statement for health care professionals from the CRP Pooling Project members. Stroke 2005 36 : 1316 1329.
25. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 2005 294 : 1799 1809.
26. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J. Am. Coll. Cardiol. 2006 48 : 2235 2242.
27. Woodward M, Lowe GD, Campbell DJ et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005 36 : 2143 2147.
28. Welsh P, Lowe GD, Chalmers J et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008 39 : 2226 2230.
29. Zhang W, Liu AJ, Yi-Ming W, Liu JG, Shen FM, Su DF. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. ClExp. Pharmacol. Physiol. 2008 35 : 83 8.
30. Heilbronn LK, Clifton PM. C-Reactive protein and coronary artery disease: Influence of obesity, caloric restriction and weight loss. J. Nutr. Biochem. 2002 13 : 316 321.
31. Plunet WT, Streijger F, Lam CK, Lee JH, Liu J, Tetzlaff W. Dietary restriction started after spinal cord injury improves functional recovery. Exp. Neurol. 2008 213 : 28 35.
32. Yusuf S, Diener HC, Sacco RL et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med. 2008 359 : 1225 1237.
33. Pavlov VA, Tracey KJ. Controlling inflammation: The cholinergic anti-inflammatory pathway. Biochem. Soc. Trans. 2006 34 : 1037 1040.
34. Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation 1996 93 : 1170 1176.
35. Sourander L, Rajala T, Räihä I, Mäkinen J, Erkkola R, Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 1998 352 : 1965 1969.
36. American. Heart Association. Heart Disease and Stroke Statistics, 2003 Update. American Heart Association, Dallas. 2002.
37. Bousser MG. Stroke in women: The 1997 Paul Dudley White International Lecture. Circulation 1999 99 : 463 467.
38. Saleh TM, Connell BJ. Role of oestrogen in the central regulation of autonomic function. ClExp. Pharmacol. Physiol. 2007 34 : 827 832.
39. Miller VM, Jayachandran M, Owen WG. Ageing, oestrogen, platelets and thrombotic risk. ClExp. Pharmacol. Physiol. 2007 34 : 814 821.
40. Leung SW, Teoh H, Keung W, Man RY. Non-genomic vascular actions of female sex hormones: Physiological implications and signalling pathways. ClExp. Pharmacol. Physiol. 2007 34 : 822 826.
41. Lemaitre RN, Weiss NS, Smith NL et al. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Arch. Intern. Med. 2006 166 : 357 365.
42. Wassertheil-Smoller S, Hendrix SL, Limacher M et al. Effect of estrogen plus progestin on stroke in postmeno pausal women. The Women's Health Initiative: A randomized trial. JAMA 2003 289 : 2673 2684.
43. Cummings SR, Ettinger B, Delmas PD et al. The effects of tibolone in older postmenopausal women. N. Engl. J. Med. 2008 359 : 697 708.
44. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P. 13th Workshop consensus for vitamin D nutritional guidelines. J. Steroid Biochem. Mol. Biol. 2007 103 : 204 205.
45. Poole KE, Loveridge N, Barker PJ et al. Reduced vitamin D in acute stroke. Stroke 2006 37 : 243 245.
46. Marniemi J, Alanen E, Impivaara O et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr. Metab. Cardiovasc. Dis. 2005 15 : 188 197.
47. Pilz S, Dobnig H, Fischer JE et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008 39 : 2611 2613.
48. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am. J. ClNutr. 2007 85 : 6 18.
49. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am. J. ClNutr. 2005 82 : 806 812.
50. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002 288 : 2015 2022.
51. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006 354 : 1567 1577.
52. Yang Q, Botto LD, Erickson JD et al. Improvement in stroke mortality in Canada and the United States, 1990-2002. Circulation 2006 113 : 1335 1343.
53. Wang X, Qin X, Demirtas H et al. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007 369 : 1876 1882.
54. Kelly TN, Gu D, Chen J et al. Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 2008 39 : 1688 1693.
55. Bazzano LA, Gu D, Reynolds K et al. Alcohol consumption and risk for stroke among Chinese men. Ann. Neurol. 2007 62 : 569 578.
56. Winter Y, Rohrmann S, Linseisen J et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008 39 : 3145 3151.
57. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation 2008 118 : 947 954.
58. Kurth T, Moore SC, Gaziano JM et al. Healthy lifestyle and the risk of stroke in women. Arch. Intern. Med. 2006 166 : 1403 1409.
59. Baliga BS, Weinberger J. Diabetes and stroke. Part one: Risk factors and pathophysiology. Curr. Cardiol. Rep. 2006 8 : 23 8.
60. Salaycik KJ, Kelley-Hayes M, Beiser A et al. Depressive symptoms and risk of stroke: The Framingham Study. Stroke 2007 38 : 1 3.
61. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007 68 : 556 562.
62. Nassief A, Marsh JD. Statin therapy for stroke prevention. Stroke 2008 39 : 1042 1048.
63. Chalmers J, Todd A, Chapman N et al. Statement on blood pressure lowering and stroke prevention. J. Hypertens. 2003 21 : 651 663.
64. Ohkubo T, Asayama K, Kikuya M et al. Prediction of ischaemic and haemorrhagic stroke by self-measured blood pressure at home: The Ohasama Study. Blood. Pressure Monit. 2004 9 : 315 320.
65. Luepker RV, Arnett DK, Jacobs DR Jr. et al. Trends in blood pressure, hypertension control, and stroke mortality: The Minnesota Heart Survey. Am. J. Med. 2006 119 : 42 9.
66. Mochizuki S, Dahlöf B, Shimizu M et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): A randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007 369 : 1431 1439.
67. Zhang H, Thijs L, Staessen JA. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006 48 : 187 195.
68. Ling G, Liu AJ, Shen FM, Cai GJ, Liu JG, Su DF. Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats. Acta Pharmacol. S2007 28 : 1755 1760.